LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields TTFields, 150 kHz Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT06216301

Study #:
STUDY00160303

Start Date:
Jan 23, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06216301

View Complete Trial Details & Eligibility at ClinicalTrials.gov